Dna X SONM Estimates

NASDAQ SONM
$4.19 -0.16 (-3.68%)
At close: Sep 29, 2026 · 4:00 PM EDT
Analyst Estimates

DNA X, Inc. Revenue Estimates

Periods 14
Next Period Q1 26
Consensus 33.92 M

Analysts expect DNA X, Inc. to report revenue of 33.92 M for Q1 26, against a range of 32.35 M to 35.49 M. The most recent reported quarter, Q3 25, came in at 16.21 M, a 51.4% miss against the 33.35 M consensus.

Metric Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27
Reported (Actual) 11.50 M15.02 M15.00 M16.72 M11.20 M16.21 M--------
High Estimate 12.40 M15.45 M19.21 M26.58 M30.26 M36.36 M35.49 M39.02 M41.06 M36.74 M64.06 M73.34 M76.31 M69.23 M
Low Estimate 10.88 M12.68 M17.27 M22.69 M25.71 M30.33 M32.35 M36.70 M33.95 M33.32 M59.14 M65.41 M64.13 M62.64 M
Consensus Estimate 11.64 M14.07 M18.24 M24.64 M27.98 M33.35 M33.92 M37.86 M37.51 M35.03 M61.60 M69.37 M70.22 M65.93 M
Analyst Estimates

DNA X, Inc. Earnings Per Share (EPS) Estimates

Periods 14
Next Period Q3 26
Consensus 4.73

Analysts expect DNA X, Inc. to report earnings per share of 4.73 for Q3 26, against a range of 4.37 to 5.09. The most recent reported quarter, Q2 26, came in at -0.92, a 117.0% miss against the 5.43 consensus.

Metric Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27
Reported (Actual) -25.38-9.36-81.001.44-14.22-4.835.01-0.92------
High Estimate -8.61-11.53-6.97-2.340.795.425.755.915.095.4342.7427.0521.43-13.46
Low Estimate -9.95-13.57-8.15-2.540.694.764.774.954.374.8935.1625.3317.67-15.58
Consensus Estimate -9.28-12.55-7.56-2.440.745.095.265.434.735.1638.9526.1919.55-14.52

DNA X, Inc. Estimates API

Pull Wall Street consensus for DNA X, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=SONM&mode=revenue&api_key=YOUR_API_KEY